Cosmos Health Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COSM research report →
Companywww.cosmosholdingsinc.com
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace.
- CEO
- Grigorios Siokas
- IPO
- 2010
- Employees
- 149
- HQ
- Chicago, IL, US
Price Chart
Valuation
- Market Cap
- $14.45M
- P/E
- -0.63
- P/S
- 0.21
- P/B
- 0.68
- EV/EBITDA
- -1.39
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 10.40%
- Op Margin
- -25.75%
- Net Margin
- -30.41%
- ROE
- -96.48%
- ROIC
- -57.22%
Growth & Income
- Revenue
- $65.27M · 19.93%
- Net Income
- $-19,144,998 · -18.30%
- EPS
- $-0.63 · 46.15%
- Op Income
- $-16,540,819
- FCF YoY
- -4.53%
Performance & Tape
- 52W High
- $1.32
- 52W Low
- $0.28
- 50D MA
- $0.34
- 200D MA
- $0.60
- Beta
- 4.30
- Avg Volume
- 906.39K
Get TickerSpark's AI analysis on COSM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 12, 26 | Siokas Grigorios | buy | 388,532 |
| Feb 11, 26 | Siokas Grigorios | buy | 291,262 |
| Jan 23, 26 | Siokas Grigorios | buy | 90,325 |
| Jan 20, 26 | Siokas Grigorios | buy | 353,321 |
| Jan 14, 26 | Siokas Grigorios | buy | 493,495 |
| Jan 12, 26 | Siokas Grigorios | buy | 113,185 |
| Jan 8, 26 | Siokas Grigorios | buy | 156,190 |
| Jan 7, 26 | Siokas Grigorios | buy | 124,880 |
| Jan 6, 26 | Siokas Grigorios | buy | 133,953 |
| Dec 19, 25 | Siokas Grigorios | buy | 88,314 |
Our COSM Coverage
We haven't published any research on COSM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate COSM Report →